triethylenemelamine has been researched along with Remission, Spontaneous in 3 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konrad, H | 1 |
| Engelmann, C | 1 |
| Zubaidi, G | 1 |
| Winkelmann, RK | 1 |
| Perry, HO | 1 |
| Muller, SA | 1 |
| Schroeter, AL | 1 |
| Jordon, RE | 1 |
| Rogers, RS | 1 |
| Mashburn, LT | 1 |
3 other studies available for triethylenemelamine and Remission, Spontaneous
| Article | Year |
|---|---|
[Cytostatic therapy of lymphogranulomatosis].
Topics: Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Chlorambucil; Cyclophosphamide; Cysti | 1972 |
Treatment of Sezary syndrome.
Topics: Chlorambucil; Cyclophosphamide; Dermatitis, Exfoliative; Humans; Keratoderma, Palmoplantar; Lymphati | 1974 |
Combination chemotherapy with L-asparaginase (EC-2) using P1798 lymphosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cyclophosphami | 1971 |